Dashboard
Manage Tickers

AGENAGENUS INC

Nasdaq agenusbio.com


$ 11.98 $ 0.46 (3.99 %)    

Thursday, 09-May-2024 13:10:12 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.32 $ 0.86 (0.2 %)
DIA $ 392.80 $ 2.69 (0.69 %)
SPY $ 519.53 $ 2.10 (0.41 %)
TLT $ 90.44 $ 0.35 (0.39 %)
GLD $ 215.83 $ 1.17 (0.54 %)
$ 11.47
$ 11.52
$ 0.00 x 0
$ 0.00 x 0
$ 11.52 - $ 12.34
$ 4.78 - $ 42.60
717,486
na
233.62M
$ 1.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-14-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-16-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-16-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-10-2019 03-31-2019 10-Q
22 03-18-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-16-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-07-2017 06-30-2017 10-Q
29 05-04-2017 03-31-2017 10-Q
30 03-16-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 03-15-2016 12-31-2015 10-K
35 11-04-2015 09-30-2015 10-Q
36 08-03-2015 06-30-2015 10-Q
37 05-01-2015 03-31-2015 10-Q
38 03-16-2015 12-31-2014 10-K
39 10-31-2014 09-30-2014 10-Q
40 08-01-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-agenus-maintains-40-price-target
HC Wainwright & Co. Reiterates Buy on Agen...
05/07/2024 18:07:36

HC Wainwright & Co. analyst Emily Bodnar reiterates Agenus (NASDAQ:AGEN) with a Buy and maintains $40 price target.

outside-crc-agenus-expects-to-release-updated-phase-1-and-2-data-in-melanoma-lung-cancer-sarcoma-and-pancreatic-cancer-later-this-year
Outside CRC, Agenus Expects To Release Upd...
05/07/2024 11:41:35

agenus-q1-2024-gaap-eps-304-beats-314-estimate-sales-28005m-miss-39268m-estimate
Agenus Q1 2024 GAAP EPS $(3.04) Beats $(3....
05/07/2024 11:40:24

Agenus (NASDAQ:AGEN) reported quarterly losses of $(3.04) per share which beat the analyst consensus estimate of $(3.14) by 3.1...

Core News & Articles
Ligand And Agenus Enter Into $100M Royalty...
05/07/2024 11:31:58

 Capital infusion will support botensilimab and balstilimab (BOT/BAL) clinical development, confirmatory Phase 3 trial, and lau...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
04/26/2024 16:31:22

top-2-health-care-stocks-which-could-rescue-your-portfolio-this-month
Top 2 Health Care Stocks Which Could Rescu...
04/23/2024 12:36:54

why-jpmorgan-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-fridays-mid-day-session
Why JPMorgan Shares Are Trading Lower By A...
04/12/2024 18:47:23

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

small-cap-cancer-drug-developer-agenus-highlights-encouraging-data-from-colorectal-cancer-but-funding-concerns-loom
Small-Cap Cancer Drug Developer Agenus' Hi...
04/12/2024 18:18:41

The latest Phase 1 trial results of Agenus' botensilimab and balstilimab (BOT/BAL) combination therapy for metastatic CRC s...

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
04/12/2024 12:55:04

agenus-announces-updated-phase-1-data-and-progress-on-botbal-development-in-metastatic-mss-colorectal-cancer-updated-phase-1-data-demonstrate-12-month-overall-survival-os-of-71-and-18-month-os-of-62
Agenus Announces Updated Phase 1 Data and ...
04/12/2024 11:32:55

Company plans to discuss encouraging Phase 2 interim results with the FDA Company plans to submit Phase 2 data to a major medi...

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
04/11/2024 23:50:04

gold-moves-higher-auddia-shares-surge
Gold Moves Higher; Auddia Shares Surge
04/08/2024 18:51:57

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 0.1% on Monday. The Dow traded u...

why-agenus-shares-are-trading-lower-by-around-17-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Agenus Shares Are Trading Lower By Aro...
04/08/2024 17:10:02

Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of ...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
04/08/2024 16:31:21

crude-oil-moves-lower-perion-network-shares-tumble
Crude Oil Moves Lower; Perion Network Shar...
04/08/2024 16:12:36

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 50 points on Monday. The Dow traded u...

radcom-lotus-technology-and-3-stocks-to-watch-heading-into-monday
RADCOM, Lotus Technology And 3 Stocks To W...
04/08/2024 07:19:46

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as foll...

agenus-announces-a-1-for-20-reverse-stock-split-of-common-stock-which-will-go-into-effect-on-april-12-2024
Agenus Announces A 1-For-20 Reverse Stock ...
04/05/2024 20:33:11

Agenus Inc. (NASDAQ:AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today an...

b-riley-securities-maintains-buy-on-agenus-lowers-price-target-to-5
B. Riley Securities Maintains Buy on Agenu...
03/18/2024 13:23:23

B. Riley Securities analyst Yuan Zhi maintains Agenus (NASDAQ:AGEN) with a Buy and lowers the price target from $6 to $5.

hc-wainwright--co-maintains-buy-on-agenus-maintains-8-price-target
HC Wainwright & Co. Maintains Buy on Agenu...
03/14/2024 15:04:44

HC Wainwright & Co. analyst Emily Bodnar maintains Agenus (NASDAQ:AGEN) with a Buy and maintains $8 price target.

agenus-q4-eps-013-misses-005-estimate-sales-8380m-may-not-be-comparable-to-4705m-estimate
Agenus Q4 EPS $(0.13) Misses $(0.05) Estim...
03/14/2024 11:32:25

Agenus (NASDAQ:AGEN) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.05) by 1...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION